Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Dietary weight loss in insulin-resistant non-obese humans: Metabolic benefits and relationship to adipose cell size.

McLaughlin T, Abbasi F, Lamendola C, Yee G, Carter S, Cushman SW.

Nutr Metab Cardiovasc Dis. 2019 Jan;29(1):62-68. doi: 10.1016/j.numecd.2018.09.014. Epub 2018 Oct 11.

PMID:
30497926
2.

American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations.

Sasson C, Eckel R, Alger H, Bozkurt B, Carson A, Daviglus M, Deedwania P, Kirley K, Lamendola C, Nguyen M, Rajgopal Singh R, Wang T, Sanchez E.

J Am Heart Assoc. 2018 Aug 7;7(15):e009271. doi: 10.1161/JAHA.118.009271. No abstract available.

3.

Access to Innovative Medicine: A Preventive Cardiovascular Nurses Association Position Statement to Reduce the Barriers.

Lamendola C, Champagne MA, Nelson Worel J, Coke LA.

J Cardiovasc Nurs. 2018 May/Jun;33(3):199-201. doi: 10.1097/JCN.0000000000000492. No abstract available.

PMID:
29634645
4.

Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea.

Liu A, Abbasi F, Kim SH, Ariel D, Lamendola C, Cardell J, Xu S, Patel S, Tomasso V, Mojaddidi H, Grove K, Tsao PS, Kushida CA, Reaven GM.

Am J Cardiol. 2017 Apr 15;119(8):1205-1210. doi: 10.1016/j.amjcard.2016.12.034. Epub 2017 Jan 25.

5.

Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome.

Perelman D, Coghlan N, Lamendola C, Carter S, Abbasi F, McLaughlin T.

Gynecol Endocrinol. 2017 Apr;33(4):324-327. doi: 10.1080/09513590.2016.1259407. Epub 2016 Dec 2.

PMID:
27910718
6.

Does enhanced insulin sensitivity improve sleep measures in patients with obstructive sleep apnea: a randomized, placebo-controlled pilot study.

Liu A, Kim SH, Ariel D, Abbasi F, Lamendola C, Cardell J, Xu S, Patel S, Tomasso V, Mojaddidi H, Grove K, Tsao PS, Kushida CA, Reaven GM.

Sleep Med. 2016 Jun;22:57-60. doi: 10.1016/j.sleep.2016.06.005. Epub 2016 Jun 21.

7.

Comparison of the association with sleep apnoea of obesity versus insulin resistance.

Liu A, Ariel D, Lamendola C, Kim SH, Abbasi F, Cardell J, Tomasso V, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Eur Respir J. 2015 Dec;46(6):1829-32. doi: 10.1183/13993003.01087-2015. Epub 2015 Sep 24. No abstract available.

8.

Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individuals.

Ariel D, Kim SH, Liu A, Abbasi F, Lamendola CA, Grove K, Tomasso V, Reaven GM.

J Clin Lipidol. 2015 Sep-Oct;9(5):658-63. doi: 10.1016/j.jacl.2015.06.009. Epub 2015 Jun 18.

9.

Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention.

Flowers E, Aouizerat BE, Abbasi F, Lamendola C, Grove KM, Fukuoka Y, Reaven GM.

Metabolism. 2015 Sep;64(9):1051-9. doi: 10.1016/j.metabol.2015.05.013. Epub 2015 May 28.

10.

Usefulness of fetuin-A to predict risk for cardiovascular disease among patients with obstructive sleep apnea.

Liu A, Lamendola C, Ariel D, Abbasi F, Kim SH, Cardell J, Tomasso V, Xu S, Patel S, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Am J Cardiol. 2015 Jul 15;116(2):219-24. doi: 10.1016/j.amjcard.2015.04.014. Epub 2015 Apr 18.

11.

In vivo 2H2O administration reveals impaired triglyceride storage in adipose tissue of insulin-resistant humans.

Allister CA, Liu LF, Lamendola CA, Craig CM, Cushman SW, Hellerstein MK, McLaughlin TL.

J Lipid Res. 2015 Feb;56(2):435-9. doi: 10.1194/jlr.M052860. Epub 2014 Nov 23.

12.

Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance.

Liu A, Cardell J, Ariel D, Lamendola C, Abbasi F, Kim SH, Holmes TH, Tomasso V, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Sleep. 2015 May 1;38(5):793-9. doi: 10.5665/sleep.4678.

13.

T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans.

McLaughlin T, Liu LF, Lamendola C, Shen L, Morton J, Rivas H, Winer D, Tolentino L, Choi O, Zhang H, Hui Yen Chng M, Engleman E.

Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2637-43. doi: 10.1161/ATVBAHA.114.304636. Epub 2014 Oct 23.

14.

Effect of liraglutide administration and a calorie-restricted diet on lipoprotein profile in overweight/obese persons with prediabetes.

Ariel D, Kim SH, Abbasi F, Lamendola CA, Liu A, Reaven GM.

Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):1317-22. doi: 10.1016/j.numecd.2014.06.010. Epub 2014 Jun 28.

PMID:
25280957
15.

Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study.

Kim SH, Liu A, Ariel D, Abbasi F, Lamendola C, Grove K, Tomasso V, Ochoa H, Reaven G.

Diabetes Care. 2014 Jul;37(7):1944-50. doi: 10.2337/dc13-2977.

16.

Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study.

Kim SH, Liu A, Ariel D, Abbasi F, Lamendola C, Grove K, Tomasso V, Reaven G.

Diabetologia. 2014 Mar;57(3):455-62. doi: 10.1007/s00125-013-3134-3. Epub 2013 Dec 11.

17.

Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes.

Kim SH, Abbasi F, Lamendola C, Liu A, Ariel D, Schaaf P, Grove K, Tomasso V, Ochoa H, Liu YV, Chen YD, Reaven G.

Diabetes Care. 2013 Oct;36(10):3276-82. doi: 10.2337/dc13-0354. Epub 2013 Jul 8.

18.

Subcutaneous adipose cell size and distribution: relationship to insulin resistance and body fat.

McLaughlin T, Lamendola C, Coghlan N, Liu TC, Lerner K, Sherman A, Cushman SW.

Obesity (Silver Spring). 2014 Mar;22(3):673-80. doi: 10.1002/oby.20209. Epub 2013 Dec 17.

19.

Relations between obesity, insulin resistance, and 25-hydroxyvitamin D.

Lamendola CA, Ariel D, Feldman D, Reaven GM.

Am J Clin Nutr. 2012 May;95(5):1055-9. doi: 10.3945/ajcn.111.032060. Epub 2012 Mar 21.

20.

Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity.

McLaughlin T, Lamendola C, Liu A, Abbasi F.

J Clin Endocrinol Metab. 2011 Nov;96(11):E1756-60. doi: 10.1210/jc.2011-0615. Epub 2011 Aug 24.

21.

Use of a two-stage insulin infusion study to assess the relationship between insulin suppression of lipolysis and insulin-mediated glucose uptake in overweight/obese, nondiabetic women.

McLaughlin T, Yee G, Glassford A, Lamendola C, Reaven G.

Metabolism. 2011 Dec;60(12):1741-7. doi: 10.1016/j.metabol.2011.05.008. Epub 2011 Aug 4.

22.

Insulin resistance and cardiovascular disease risk factors in subjects with prehypertension.

Knobler H, Abbasi F, Lamendola C, Reaven GM.

Diab Vasc Dis Res. 2011 Jan;8(1):43-6. doi: 10.1177/1479164110396919.

PMID:
21262870
23.

Glucose-stimulated insulin secretion in gastric bypass patients with hypoglycemic syndrome: no evidence for inappropriate pancreatic beta-cell function.

Kim SH, Abbasi F, Lamendola C, Reaven GM, McLaughlin T.

Obes Surg. 2010 Aug;20(8):1110-6. doi: 10.1007/s11695-010-0183-2.

PMID:
20665189
24.

What is the effect of rosiglitazone treatment on insulin secretory function in insulin-resistant individuals? It depends on how you measure it.

Abbasi F, Lamendola C, Reaven GM.

Metabolism. 2011 Jan;60(1):57-62. doi: 10.1016/j.metabol.2010.02.015. Epub 2010 Mar 30.

PMID:
20356610
25.

Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents.

Kim SH, Nikolics L, Abbasi F, Lamendola C, Link J, Reaven GM, Lindley S.

J Psychiatr Res. 2010 Jun;44(8):493-8. doi: 10.1016/j.jpsychires.2009.11.007. Epub 2009 Dec 3.

26.

Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue.

McLaughlin TM, Liu T, Yee G, Abbasi F, Lamendola C, Reaven GM, Tsao P, Cushman SW, Sherman A.

Obesity (Silver Spring). 2010 May;18(5):926-31. doi: 10.1038/oby.2009.380. Epub 2009 Nov 12.

27.

Inflammation in subcutaneous adipose tissue: relationship to adipose cell size.

McLaughlin T, Deng A, Yee G, Lamendola C, Reaven G, Tsao PS, Cushman SW, Sherman A.

Diabetologia. 2010 Feb;53(2):369-77. doi: 10.1007/s00125-009-1496-3. Epub 2009 Oct 9.

28.

Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women.

Liu A, McLaughlin T, Liu T, Sherman A, Yee G, Abbasi F, Lamendola C, Morton J, Cushman SW, Reaven GM, Tsao PS.

Obes Surg. 2009 Nov;19(11):1564-73. doi: 10.1007/s11695-009-9949-9. Epub 2009 Aug 27.

29.

Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia.

Kim SH, Liu TC, Abbasi F, Lamendola C, Morton JM, Reaven GM, McLaughlin TL.

Obes Surg. 2009 Nov;19(11):1550-6. doi: 10.1007/s11695-009-9893-8. Epub 2009 Jun 26.

PMID:
19557485
30.

Pioglitazone decreases postprandial accumulation of remnant lipoproteins in insulin-resistant smokers.

Abbasi F, Lamendola C, Leary ET, Reaven GM.

Diabetes Obes Metab. 2009 Aug;11(8):779-85. doi: 10.1111/j.1463-1326.2009.01041.x. Epub 2009 May 19. Erratum in: Diabetes Obes Metab. 2009 Oct;11(10):996.

PMID:
19476476
31.

Effect of moderate alcoholic beverage consumption on insulin sensitivity in insulin-resistant, nondiabetic individuals.

Kim SH, Abbasi F, Lamendola C, Reaven GM.

Metabolism. 2009 Mar;58(3):387-92. doi: 10.1016/j.metabol.2008.10.013.

33.

Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women.

McLaughlin T, Deng A, Gonzales O, Aillaud M, Yee G, Lamendola C, Abbasi F, Connolly AJ, Sherman A, Cushman SW, Reaven G, Tsao PS.

Diabetologia. 2008 Dec;51(12):2303-8. doi: 10.1007/s00125-008-1148-z. Epub 2008 Sep 30.

34.

Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension.

Lima NK, Abbasi F, Lamendola C, Reaven GM.

Am J Hypertens. 2009 Jan;22(1):106-11. doi: 10.1038/ajh.2008.263. Epub 2008 Sep 4.

PMID:
18772854
35.

Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers.

Abbasi F, Farin HM, Lamendola C, McGraw L, McLaughlin T, Reaven GM.

Metabolism. 2008 Aug;57(8):1108-14. doi: 10.1016/j.metabol.2008.03.016.

PMID:
18640389
36.

Comparison of three treatment approaches to decreasing cardiovascular disease risk in nondiabetic insulin-resistant dyslipidemic subjects.

Abbasi F, Chen YD, Farin HM, Lamendola C, Reaven GM.

Am J Cardiol. 2008 Jul 1;102(1):64-9. doi: 10.1016/j.amjcard.2008.02.097. Epub 2008 May 2.

37.

Persistence of improvement in insulin sensitivity following a dietary weight loss programme.

McLaughlin T, Schweitzer P, Carter S, Yen CG, Lamendola C, Abbasi F, Reaven G.

Diabetes Obes Metab. 2008 Dec;10(12):1186-94. doi: 10.1111/j.1463-1326.2008.00877.x. Epub 2008 May 12.

PMID:
18476986
38.

The therapeutic efficacy of rosiglitazone is enhanced in sulphonylurea-treated patients with type 2 diabetes.

Itakura H, Abbasi F, Lamendola C, Basina M, Reaven G.

Diabetes Obes Metab. 2008 Aug;10(8):685-7. doi: 10.1111/j.1463-1326.2008.00888.x. Epub 2008 May 12. No abstract available.

PMID:
18476981
39.

Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.

Kim SH, Ivanova O, Abbasi FA, Lamendola CA, Reaven GM, Glick ID.

J Clin Psychopharmacol. 2007 Aug;27(4):365-8.

PMID:
17632220
40.

Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.

Palaniappan LP, Kwan AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven GM.

Metabolism. 2007 Jul;56(7):899-904.

PMID:
17570249
41.

Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis.

McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, Lamendola C, Reaven GM, Cushman SW.

Diabetologia. 2007 Aug;50(8):1707-15. Epub 2007 Jun 5.

PMID:
17549449
42.

Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes: comparison of moderate fat versus carbohydrate reductions.

McLaughlin T, Carter S, Lamendola C, Abbasi F, Schaaf P, Basina M, Reaven G.

Diabetes Care. 2007 Jul;30(7):1877-9. Epub 2007 May 2. No abstract available.

PMID:
17475941
43.
44.

Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults.

Ryan MC, Abbasi F, Lamendola C, Carter S, McLaughlin TL.

Diabetes Care. 2007 May;30(5):1075-80. Epub 2007 Mar 10.

PMID:
17351275
45.

Whole-body glycolysis measured by the deuterated-glucose disposal test correlates highly with insulin resistance in vivo.

Beysen C, Murphy EJ, McLaughlin T, Riiff T, Lamendola C, Turner HC, Awada M, Turner SM, Reaven G, Hellerstein MK.

Diabetes Care. 2007 May;30(5):1143-9. Epub 2007 Jan 26.

PMID:
17259480
46.

The relationship between insulin resistance and dyslipidaemia in cigarette smokers.

Farin HM, Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM.

Diabetes Obes Metab. 2007 Jan;9(1):65-9.

PMID:
17199720
47.

Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults.

McLaughlin T, Carter S, Lamendola C, Abbasi F, Yee G, Schaaf P, Basina M, Reaven G.

Am J Clin Nutr. 2006 Oct;84(4):813-21.

PMID:
17023708
48.

The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers.

Abbasi F, Farin HM, Lamendola C, McLaughlin T, Schwartz EA, Reaven GM, Reaven PD.

J Clin Endocrinol Metab. 2006 Dec;91(12):5002-7. Epub 2006 Sep 26.

PMID:
17003098
49.

Intraoperative assessment of mitral regurgitation: role of phenylephrine challenge.

Mihalatos DG, Gopal AS, Kates R, Toole RS, Bercow NR, Lamendola C, Berkay SH, Damus P, Robinson N, Grimson R, Shen K, Reichek N.

J Am Soc Echocardiogr. 2006 Sep;19(9):1158-64.

PMID:
16950471
50.

Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss.

McLaughlin T, Stühlinger M, Lamendola C, Abbasi F, Bialek J, Reaven GM, Tsao PS.

J Clin Endocrinol Metab. 2006 May;91(5):1896-900. Epub 2006 Feb 28.

PMID:
16507636

Supplemental Content

Loading ...
Support Center